Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 4 studies | 28% ± 7% | |
glutamatergic neuron | 4 studies | 30% ± 10% | |
neuron | 4 studies | 26% ± 7% | |
oligodendrocyte | 3 studies | 17% ± 0% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 861.45 | 245 / 245 | 99% | 3.70 | 498 / 502 |
ovary | 100% | 1517.79 | 180 / 180 | 98% | 5.15 | 423 / 430 |
breast | 100% | 817.78 | 458 / 459 | 98% | 4.84 | 1095 / 1118 |
brain | 100% | 1230.11 | 2641 / 2642 | 98% | 6.64 | 689 / 705 |
thymus | 100% | 920.68 | 653 / 653 | 97% | 4.10 | 589 / 605 |
adrenal gland | 100% | 1719.57 | 258 / 258 | 97% | 4.26 | 222 / 230 |
esophagus | 99% | 636.97 | 1424 / 1445 | 98% | 3.52 | 179 / 183 |
bladder | 100% | 897.57 | 21 / 21 | 96% | 3.88 | 482 / 504 |
lung | 100% | 798.61 | 578 / 578 | 95% | 3.23 | 1103 / 1155 |
intestine | 100% | 821.68 | 966 / 966 | 94% | 2.93 | 495 / 527 |
skin | 98% | 411.24 | 1781 / 1809 | 95% | 5.61 | 449 / 472 |
stomach | 100% | 735.69 | 359 / 359 | 93% | 3.38 | 266 / 286 |
kidney | 100% | 765.28 | 89 / 89 | 92% | 3.14 | 826 / 901 |
pancreas | 100% | 864.44 | 328 / 328 | 92% | 2.36 | 163 / 178 |
uterus | 100% | 1264.03 | 170 / 170 | 89% | 3.42 | 409 / 459 |
liver | 100% | 729.42 | 226 / 226 | 67% | 1.52 | 271 / 406 |
spleen | 100% | 624.79 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.26 | 1 / 1 |
muscle | 100% | 891.67 | 802 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 667.25 | 1199 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 490.19 | 1326 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 475.61 | 832 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 2.45 | 37 / 45 |
eye | 0% | 0 | 0 / 0 | 68% | 1.83 | 54 / 80 |
lymph node | 0% | 0 | 0 / 0 | 59% | 0.96 | 17 / 29 |
peripheral blood | 25% | 135.56 | 228 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042475 | Biological process | odontogenesis of dentin-containing tooth |
GO_0035265 | Biological process | organ growth |
GO_0007498 | Biological process | mesoderm development |
GO_0032924 | Biological process | activin receptor signaling pathway |
GO_0060841 | Biological process | venous blood vessel development |
GO_0007178 | Biological process | cell surface receptor protein serine/threonine kinase signaling pathway |
GO_0030324 | Biological process | lung development |
GO_0001974 | Biological process | blood vessel remodeling |
GO_0009791 | Biological process | post-embryonic development |
GO_0009749 | Biological process | response to glucose |
GO_0031016 | Biological process | pancreas development |
GO_0060836 | Biological process | lymphatic endothelial cell differentiation |
GO_0007507 | Biological process | heart development |
GO_0007368 | Biological process | determination of left/right symmetry |
GO_0007165 | Biological process | signal transduction |
GO_0001822 | Biological process | kidney development |
GO_0001946 | Biological process | lymphangiogenesis |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032927 | Biological process | positive regulation of activin receptor signaling pathway |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0061298 | Biological process | retina vasculature development in camera-type eye |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0060021 | Biological process | roof of mouth development |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0009952 | Biological process | anterior/posterior pattern specification |
GO_0030073 | Biological process | insulin secretion |
GO_0060840 | Biological process | artery development |
GO_0006468 | Biological process | protein phosphorylation |
GO_0030501 | Biological process | positive regulation of bone mineralization |
GO_0048617 | Biological process | embryonic foregut morphogenesis |
GO_0048705 | Biological process | skeletal system morphogenesis |
GO_0001702 | Biological process | gastrulation with mouth forming second |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0048179 | Cellular component | activin receptor complex |
GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0048185 | Molecular function | activin binding |
GO_0019209 | Molecular function | kinase activator activity |
GO_0017002 | Molecular function | activin receptor activity |
GO_0019838 | Molecular function | growth factor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0016362 | Molecular function | activin receptor activity, type II |
GO_0005515 | Molecular function | protein binding |
Gene name | ACVR2B |
Protein name | Serine/threonine-protein kinase receptor (EC 2.7.11.30) Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB) |
Synonyms | |
Description | FUNCTION: Transmembrane serine/threonine kinase activin type-2 receptor forming an activin receptor complex with activin type-1 serine/threonine kinase receptors (ACVR1, ACVR1B or ACVR1c). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, the type-2 receptors act as a primary activin receptors (binds activin-A/INHBA, activin-B/INHBB as well as inhibin-A/INHA-INHBA). The type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor. . |
Accessions | Q13705 ENST00000352511.5 [Q13705-1] Q4VAU9 |